זימבאבווה - אנגלית - Medicines Control Authority

mylan laboratories limited - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet; oral - 600; 200; 300mg

זימבאבווה - אנגלית - Medicines Control Authority

aurobindo pharma limited - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet, coated; oral - 600; 200; 300 mg

זימבאבווה - אנגלית - Medicines Control Authority

macleods pharmaceuticals ltd - efavirenz; emtricitabine; tenofovir disoproxil fumarate - tablet; oral - 600; 200; 300 mg

אוגנדה - אנגלית - National Drug Authority

aurobindo pharma ltd - efavirenz + emtricitabine + tenofovir disoproxil fumarate - oral solid ordinary film-coated tablets - 600mg +200mg + 300mg

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - tenofovir disoproxil succinate 300.6mg equivalent to tenofovir disoproxil 245 mg;   - film coated tablet - 245 mg - active: tenofovir disoproxil succinate 300.6mg equivalent to tenofovir disoproxil 245 mg   excipient: croscarmellose sodium indigo carmine aluminium lake lactose macrogol 3350 magnesium stearate microcrystalline cellulose polyvinyl alcohol pregelatinised maize starch purified talc purified water titanium dioxide - tenofovir disoproxil tablets in combination with other antiretroviral agents are indicated for the treatment of hiv-infected adults and paediatric patients 12 years of age and older.

נמיביה - אנגלית - Namibia Medicines Regulatory Council

strides arcolab limited - efavirenz+emtricitabine+tenofovir disoproxil fumarate - tablet - each tablet contains efavirenz 600mg, 200mg emtricitabine and 300mg tenofovir disoproxil fumarate

אירלנד - אנגלית - HPRA (Health Products Regulatory Authority)

accord healthcare limited - tenofovir disoproxil; emtricitabine - film-coated tablet - 200mg/245 milligram(s) - antivirals for treatment of hiv infections, combinations; tenofovir disoproxil and emtricitabine

ניו זילנד - אנגלית - Medsafe (Medicines Safety Authority)

teva pharma (new zealand) limited - emtricitabine 200mg; tenofovir disoproxil succinate 300.6mg equivalent to tenofovir disoproxil 245mg;   - film coated tablet - active: emtricitabine 200mg tenofovir disoproxil succinate 300.6mg equivalent to tenofovir disoproxil 245mg   excipient: croscarmellose sodium indigo carmine aluminium lake lactose monohydrate macrogol 3350 magnesium stearate microcrystalline cellulose polyvinyl alcohol pregelatinised maize starch purified talc purified water titanium dioxide - indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - emtricitabine, quantity: 200 mg; tenofovir disoproxil maleate, quantity: 300 mg - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; colloidal anhydrous silica; iron oxide red; microcrystalline cellulose; hyprolose; titanium dioxide; hypromellose; triacetin; iron oxide yellow; brilliant blue fcf aluminium lake - treatment of hiv-1 infection: tenofovir disoproxil emtricitabine mylan 300/200 is indicated for the treatment of hiv infected adults over the age of 18 years, in combination with other antiretroviral agents. pre-exposure prophylaxis: tenofovir disoproxil emtricitabine mylan 300/200 is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 in adults at high risk. this indication is based on clinical trials in men who have sex with men (msm) at high risk for hiv-1 infection and in heterosexual serodiscordant couples (see clinical studies).

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

gilead sciences pty ltd - efavirenz,emtricitabine,tenofovir disoproxil fumarate -